(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 10.87%3.89B | -24.41%7.62B | 2.77%3.51B | 68.74%10.08B | 36.44%3.42B | 23.30%5.97B | 2.10%2.51B | -8.22%4.84B | -5.95%2.45B | 3.85%5.28B |
Special items of operating revenue | -25.24%77.6M | -18.03%212.8M | 114.02%103.8M | 44.70%259.6M | -40.85%48.5M | 48.88%179.4M | 371.26%82M | -71.87%120.5M | -22.67%17.4M | 32.22%428.4M |
Operating income | 9.84%3.97B | -24.25%7.83B | 4.33%3.62B | 68.04%10.34B | 33.99%3.47B | 23.92%6.15B | 4.70%2.59B | -13.00%4.97B | -6.10%2.47B | 5.55%5.71B |
Cost of sales | -26.78%-1.46B | 33.74%-2.76B | -39.54%-1.15B | -293.01%-4.16B | -251.38%-824.7M | -100.40%-1.06B | 16.18%-234.7M | 15.26%-528M | 0.64%-280M | -25.73%-623.1M |
Operating expenses | -26.78%-1.46B | 33.74%-2.76B | -39.54%-1.15B | -293.01%-4.16B | -251.38%-824.7M | -100.40%-1.06B | 16.18%-234.7M | 15.26%-528M | 0.64%-280M | -25.73%-623.1M |
Gross profit | 1.93%2.51B | -17.87%5.08B | -6.67%2.47B | 21.32%6.18B | 12.31%2.64B | 14.82%5.09B | 7.37%2.35B | -12.72%4.44B | -6.75%2.19B | 3.51%5.08B |
Selling expenses | 21.87%-107.9M | 6.44%-264.3M | -38.79%-138.1M | -54.63%-282.5M | -107.72%-99.5M | -52.38%-182.7M | 18.12%-47.9M | 18.60%-119.9M | 17.02%-58.5M | 7.47%-147.3M |
Administrative expenses | -13.18%-956.4M | -5.47%-1.85B | 4.66%-845M | -0.61%-1.76B | 5.52%-886.3M | -9.39%-1.75B | -35.39%-938.1M | -4.92%-1.6B | 9.04%-692.9M | -5.61%-1.52B |
Revaluation surplus | -13.42%-396.4M | 81.07%-399.5M | 56.23%-349.5M | -181.81%-2.11B | -129.12%-798.5M | 4.07%2.58B | 838.25%2.74B | 25.60%2.48B | -69.93%292.3M | 132.14%1.97B |
-Changes in the fair value of investment property | -1,519.83%-487M | 121.46%70.9M | 117.18%34.3M | -506.90%-330.4M | -618.44%-199.6M | 137.13%81.2M | 133.57%38.5M | -264.81%-218.7M | -164.11%-114.7M | -82.15%132.7M |
-Changes in the fair value of financial assets | ---- | 73.58%-470.4M | ---- | -171.25%-1.78B | -122.15%-598.9M | -7.38%2.5B | 564.37%2.7B | 46.53%2.7B | -48.69%407M | 1,623.97%1.84B |
-Changes in the fair value of other assets | 123.61%90.6M | ---- | ---383.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -33.24%-436.1M | -22.95%-1.04B | 1.77%-327.3M | -23.13%-842.3M | -6.25%-333.2M | 37.17%-684.1M | 38.99%-313.6M | -2.33%-1.09B | -12.67%-514M | -17.13%-1.06B |
-Other impairment is provision | -33.24%-436.1M | -22.95%-1.04B | 1.77%-327.3M | -23.13%-842.3M | -6.25%-333.2M | 37.17%-684.1M | 38.99%-313.6M | -2.33%-1.09B | -12.67%-514M | -17.13%-1.06B |
Operating interest expense | ---- | ---- | ---- | ---- | -72.02%-430.9M | -4.83%-568.7M | 10.12%-250.5M | -12.58%-542.5M | ---278.7M | ---481.9M |
Special items of operating profit | -0.18%-171.2M | 132.03%129.5M | 50.62%-170.9M | -110.65%-404.3M | -102.87%-346.1M | 3,044.30%3.8B | -109.07%-170.6M | 40.63%-128.9M | -55.73%-81.6M | -18.31%-217.1M |
Operating profit | -29.85%445.5M | 110.99%1.65B | 351.52%635.1M | -90.55%783.3M | -107.48%-252.5M | 140.95%8.29B | 293.41%3.37B | -5.14%3.44B | -56.70%857.7M | 18.12%3.63B |
Financing cost | -4.04%-402.2M | 2.67%-822.8M | ---386.6M | ---845.4M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | 224.58%37M | 279.17%172M | 67.07%-29.7M | -119.85%-96M | -135.18%-90.2M | -21.76%483.6M | 841.04%256.4M | -38.59%618.1M | -106.70%-34.6M | 101.95%1.01B |
Share of profit from joint venture company | -133.33%-2.4M | -339.08%-379.8M | 120.45%7.2M | 45.97%-86.5M | 65.11%-35.2M | -39.10%-160.1M | -121.27%-100.9M | -223.10%-115.1M | -160.48%-45.6M | -72.19%93.5M |
Special items of earning before tax | 0.87%-22.8M | 109.77%12.8M | ---23M | ---131M | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | -72.86%55.1M | 269.04%634.9M | 153.72%203M | -104.36%-375.6M | -110.71%-377.9M | 118.42%8.61B | 353.99%3.53B | -16.57%3.94B | -66.66%777.5M | 36.45%4.73B |
Tax | 28.63%-163.3M | 49.85%-378.9M | -24.21%-228.8M | -19.20%-755.5M | 34.38%-184.2M | -121.45%-633.8M | -200.21%-280.7M | -18.36%-286.2M | 38.08%-93.5M | 4.84%-241.8M |
After-tax profit from continuing operations | -319.38%-108.2M | 122.63%256M | 95.41%-25.8M | -114.18%-1.13B | -117.30%-562.1M | 118.18%7.98B | 375.01%3.25B | -18.46%3.66B | -68.64%684M | 39.71%4.48B |
Earning after tax | -319.38%-108.2M | 122.63%256M | 95.41%-25.8M | -114.18%-1.13B | -117.30%-562.1M | 118.18%7.98B | 375.01%3.25B | -18.46%3.66B | -68.64%684M | 39.71%4.48B |
Minority profit | -23.53%105.6M | 326.62%381.4M | 216.74%138.1M | -93.06%89.4M | -95.85%43.6M | -20.43%1.29B | 107.34%1.05B | -17.10%1.62B | -49.46%506.9M | 29.26%1.95B |
Profit attributable to shareholders | -30.45%-213.8M | 89.73%-125.4M | 72.94%-163.9M | -118.25%-1.22B | -127.56%-605.7M | 228.35%6.69B | 1,141.16%2.2B | -19.50%2.04B | -84.97%177.1M | 49.01%2.53B |
Basic earnings per share | -20.00%-0.06 | 88.57%-0.04 | 70.59%-0.05 | -118.42%-0.35 | -126.98%-0.17 | 227.59%1.9 | 1,160.00%0.63 | -19.44%0.58 | -99.25%0.05 | -92.55%0.72 |
Diluted earnings per share | -20.00%-0.06 | 88.57%-0.04 | 70.59%-0.05 | -118.42%-0.35 | -127.42%-0.17 | 227.59%1.9 | 1,140.00%0.62 | -19.44%0.58 | -99.25%0.05 | -92.55%0.72 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data